Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxcarbazepine Monotherapy vs Combination with Gabapentin in Trigeminal Neuralgia
NCT07625410Phase 3Completed
- Sponsor
- Rehman Medical Institute
- Start
- May 2023
- Primary completion
- May 2024
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in trigeminal neuralgia (TN), sponsored by Rehman Medical Institute. Started May 2023; status: completed.
02
Drugs
gabapentin
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT07625410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07625410.